Dr. Geert Tits

Active

Private limited companyfounded 2006active for 19 yearsSchuiferskapelsesteenweg 33, 8700 Tielt, BelgiumKBO/BCE: BE 0885.801.030

Summary

Dr. Geert Tits has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €345,730 and a net result of €44,436. Equity remains stable across the filed financial years (±0.2% per year). Its solvency ranks better than 74% of 613 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

Dr. Geert TitsActiveChecked score 96/100

Risk analysis Report Compare

Activity

Research and development on biotechnology

NACE 72101

1 site

Size

€413,561total assets 2025

Equity: €345,730
Profit: €44,436

Turnover not published (micro format)

Financial health

96 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: < 0.1%

Structure

2025 accounts 30 days early3 deeds in the Belgian Official Gazette

Why 96lowers riskLiquidity: current ratio 4.76, cash €179,264Equity €345,730 (83.6% of total assets)Founded in 2006Figures for financial year 2025 (filed 01-07-2026)Show the evidence

Checked score

Score 2025

96 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 67% of its sector peers (NACE 72, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 100=

equity 83.6% of total assets

Liquidity 96+32

short-term debt 16.4% · cash 43.3%

Profitability 82+3

return on assets 10.7%

Bankruptcy probability, 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (935 companies, NACE 72, micro)

Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: 0.1%▲ +0.1 percentage points vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026highest value 08-2026: < 0.1%▼ -0.1 percentage points vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value

Credit of up to €30,000 on 30-day terms is acceptable

Liquidity ample (current ratio 4.76, compared with 3.41 in 2024, above the usual 1.5; short-term debt: 16.4% and cash: 43.3% of total assets), and 16.4% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro): better than 83% on solvency, 86% on liquidity, 59% on profitability and 41% on growth.

The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskneutral

Liquidity: current ratio 4.76, cash €179,264

NBB · annual accounts

Equity €345,730 (83.6% of total assets)

NBB · annual accounts

Founded in 2006

Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.

KBO

Figures for financial year 2025 (filed 01-07-2026)

NBB · annual accounts

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 01-07-2026, 30 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

30 days early

2024

15 days early

2023

12 days early

2022

6 days early

2021

26 days late

2020

32 days late

2019

90 days late

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 12 days after the deadline; the sector median (NACE 72) for financial year 2024 is 13 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 20 July (4 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

24-10-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

01-07-2026 Annual accounts filedfinancial year 2025 · micro…
16-07-2025 Annual accounts filedfinancial year 2024 · micro…
31-12-2024 Weakest financial yearnet €36,145 ▼55.4%

Key points

Positive: 8 profitable years in a rowprofit 2025: €44,436 8 years View
Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View
Total assets 20256 financial years filed €413,561 View

By topic

Financials

Financial year: 2025
Total assets: €413,561
Profit: €44,436
Solvency: 83.6%

Total assets▼ 10.0%

Net result

20182025

Go to Financials

Timeline

Events: 22
Since: 2008
Next accounts: by 31-07-2027

19-07-2024Annual accounts filed
25-07-2023Annual accounts filed
31-12-2022Highest result from 2018 to 2025

Go to Timeline

Company details

Sites: 1

Legal form: Private limited company
Activity: Research and development on biotechnologyNACE 72101
Founded: 20-12-2006
Year ends: 31-12
Peppol: Reachable for e-invoices

Go to Company details

Key facts about Dr. Geert Tits

What is the company number of Dr. Geert Tits?: 0885.801.030. In Belgium the VAT number is the company number with BE in front: BE 0885.801.030.
Where is Dr. Geert Tits based?: The registered office is at Schuiferskapelsesteenweg 33, 8700 Tielt.Company details
What does Dr. Geert Tits do?: According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
What is the legal form of Dr. Geert Tits?: Private limited company (BV).
When was Dr. Geert Tits founded?: On 20-12-2006.
Is Dr. Geert Tits still active?: Yes, Dr. Geert Tits is an active enterprise in the KBO register.
What is the turnover of Dr. Geert Tits?: Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is Dr. Geert Tits profitable?: In financial year 2025, Dr. Geert Tits made a profit of €44,436.
Where can I find the annual accounts of Dr. Geert Tits?: Dr. Geert Tits filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Geert Tits due?: By 31-07-2027, for financial year 2026.Timeline